Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02512783 · ClinicalTrials.gov registry record · NA
Decreasing Propofol Injection Pain by Pre-Treatment With Lidocaine in Pediatric Procedural Sedation
A NA study, sponsored by Children's Hospitals and Clinics of Minnesota.
- Terminated
- Registry status
- NA
- Development phase
- 171
- Enrollment target
NCT02512783 is a NA study that was terminated before completion, run by Children's Hospitals and Clinics of Minnesota. The registered enrollment target is 171 participants.
The verdict
NCT02512783, a NA study, was terminated before completion, sponsored by Children's Hospitals and Clinics of Minnesota.
- TERMINATED
- Registry status
- NA
- Development phase
- 171 participants
- Enrollment target
Study Summary
This is a double blind, randomized, controlled study. The sedationist performing the sedation procedure will inject the appropriate amount of either a 1% Lidocaine solution or a placebo before the administration of Propofol. A research staff will observe the patient simultaneously with the induction of Propofol to determine the patient's pain level, as measured by the Face, Legs, Activity, Cry, Consolability (FLACC) scale. The purpose of this study is to determine the efficacy of premedication with 1% Lidocaine in decreasing the burning sensation caused by intravenous Propofol.
Interventions
- DRUG Lidocaine
- DRUG Propofol
- DRUG Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2013-05 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02512783
The ClinicalTrials.gov registry entry for NCT02512783 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospitals and Clinics of Minnesota, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Lidocaine is the first listed.
NCT02512783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02512783 about?
NCT02512783 is a clinical study titled "Decreasing Propofol Injection Pain by Pre-Treatment With Lidocaine in Pediatric Procedural Sedation". This is a double blind, randomized, controlled study. The sedationist performing the sedation procedure will inject the appropriate amount of either a 1% Lidocaine solution or a placebo before the administration of Propofol. A research staff will observe the patient simultaneously with the induction...
What is the current status of trial NCT02512783?
This trial is currently terminated. It is a NA study. The enrollment target is 171 participants. The study started on 2013-05. Estimated completion is 2014-06.
What interventions are being tested in trial NCT02512783?
The interventions under investigation include: Lidocaine (DRUG), Propofol (DRUG), Normal Saline (DRUG).
Who is sponsoring clinical trial NCT02512783?
This trial is sponsored by Children's Hospitals and Clinics of Minnesota, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.